Sofwave Medical Ltd SOFW
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Sofwave Medical Reports Third Quarter 2026 Financial Results and Business Highlights
Sofwave to Participate in Upcoming November Investor Conferences
Sofwave to Participate in the Jefferies Private MedTech Virtual Summit
Sofwave Receives NMPA Approval in Mainland China
Sofwave to Participate in the Wells Fargo 21st Annual Healthcare Conference
Sofwave Announces Publication of Data from Randomized Controlled Study of its Pure Impact™ VIP Platform Utilizing PlyoPulse™ EMS Technology in Aesthetic Surgery Journal
Sofwave Surpasses One Million Treatments Worldwide; Milestone Treatment Performed in South Korea
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 36.39M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 47.54
- Price/Sales
- 4.13
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Sofwave Medical Ltd is engaged in the development, production, marketing, and sale of systems for skin rejuvenation and firming treatments. SUPERB, Synchronous Ultrasound Parallel Beam technology, is the company's FDA-cleared technology to improve facial lines and wrinkles, lift the eyebrows and lax submental tissue (beneath the chin), lift lax skin in the arms, and provide short-term improvement in the appearance of cellulite and treatment of acne scars. Its Pure Impact module uses EMS technology and is cleared for muscle toning. Sofwave's products provide physicians with effective and safe aesthetic solutions for their patients. Geographically, it generates maximum revenue from the United States, followed by East Asia, Europe and the Middle East, and other regions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 151
- Website
- https://www.sofwave.com
Valuation
Metric | SOFW |
|---|---|
Price/Earnings (Normalized) | 47.54 |
Price/Book Value | 14.05 |
Price/Sales | 4.13 |
Price/Cash Flow | 31.02 |
Price/Earnings
SOFW
Financial Strength
Metric | SOFW |
|---|---|
Quick Ratio | 1.95 |
Current Ratio | 2.71 |
Interest Coverage | 32.73 |
Quick Ratio
SOFW
Profitability
Metric | SOFW |
|---|---|
Return on Assets (Normalized) | 22.38% |
Return on Equity (Normalized) | 59.13% |
Return on Invested Capital (Normalized) | 32.90% |
Return on Assets
SOFW
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|?%$Dhb | LOCK|GC#R | $188B | |||
| Medtronic PLC MDT | LOCK|Yz!Q!$J | LOCK|^Z@g | $132B | |||
| Stryker Corp SYK | LOCK|&^@lv@>& | LOCK|VZh | $118B | |||
| Boston Scientific Corp BSX | LOCK|Yv>bw< | LOCK|>Wf! | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|T!!y!GW | LOCK|#P>l | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|Nchr%<! | LOCK|<? | $38B | |||
| DexCom Inc DXCM | LOCK|$f&g&z<^ | LOCK|#$bfB | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|FCD | LOCK|q> | $30B | |||
| Steris PLC STE | LOCK|XgXNmr | LOCK|k@DJ | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|>N#K?YQ$ | LOCK|kkr | $20B |